Retrospective Analysis of International Normalized Ratio Management in Valve Replacement Patients to Reduce Thromboembolic and Bleeding Complications

Background: Effective management of the International Normalized Ratio (INR) is crucial for patients undergoing valve replacement surgery to
minimize the risk of thromboembolic and bleeding complications. Patients with mechanical heart valve replacements are especially vulnerable
to thrombus formation and associated risks, necessitating precise anticoagulation management. Methods: This retrospective study evaluated the
effectiveness of INR monitoring protocols in patients with mechanical heart valve replacements. The primary objectives included assessing the role
of routine prothrombin time (PT) testing, optimizing anticoagulant dosage adjustments, and examining the impact of structured patient education on
adherence to anticoagulation therapy. INR levels, their correlation with adverse clinical events, and the outcomes of consistent monitoring practices
were systematically analyzed. Results: Findings highlighted the critical importance of maintaining INR within optimal therapeutic thresholds,
which substantially reduced the incidence of thromboembolic and hemorrhagic events. Routine PT/INR testing combined with timely anticoagulant
adjustments proved effective in enhancing patient safety. Furthermore, advancements in anticoagulation therapies and emerging point‑of‑care
monitoring technologies contributed to improved clinical outcomes. The implementation of structured patient education and follow‑up systems
significantly improved therapy adherence and reduced adverse events. Conclusion: Standardized postsurgical INR management protocols are essential
to enhance the safety and effectiveness of anticoagulation therapy in valve replacement patients. Maintaining INR within target ranges lowers the
risk of thromboembolic and bleeding complications, thereby improving overall patient outcomes and reducing mortality rates. Integrating patient
education programs and robust follow‑up systems further optimizes long‑term anticoagulation management and empowers patients in their care.